Clinical Trial Update: Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating epoetin alfa or darbepoetin alfa for chemotherapy-induced anemia; results from a completed study were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Leukemia
• Lymphoma
• Lymphoproliferative Disorder
• Multiple Myeloma

Drugs mentioned

• Aranesp (darbepoetin alfa) (darbepoetin alfa)
• Epogen (epoetin alfa) (epoetin alfa)

Snippet

Sponsor: Mayo Clinic | Conditions: Anemia, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-02-10